siRNA-optimized Modifications for Enhanced In Vivo Activity
Open Access
- 1 January 2012
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 1 (1) , e5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Nucleoside Optimization for RNAi: A High-Throughput PlatformJournal of the American Chemical Society, 2011
- Crystal Structure of A. aeolicus Argonaute, a Site-Specific DNA-Guided Endoribonuclease, Provides Insights into RISC-Mediated mRNA CleavageMolecular Cell, 2005
- Positional Effect of Chemical Modifications on Short Interference RNA Activity in Mammalian CellsJournal of Medicinal Chemistry, 2005
- Purified Argonaute2 and an siRNA form recombinant human RISCNature Structural & Molecular Biology, 2005
- Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionalityNucleic Acids Research, 2005
- In vivo activity of nuclease-resistant siRNAsRNA, 2004
- Structural variations and stabilising modifications of synthetic siRNAs in mammalian cellsNucleic Acids Research, 2003
- Sequence, Chemical, and Structural Variation of Small Interfering RNAs and Short Hairpin RNAs and the Effect on Mammalian Gene SilencingAntisense and Nucleic Acid Drug Development, 2003
- Tolerance for mutations and chemical modifications in a siRNANucleic Acids Research, 2003
- Evidence that siRNAs Function as Guides, Not Primers, in the Drosophila and Human RNAi PathwaysMolecular Cell, 2002